Test Price
1,800 AED✅ Home Collection Available
Cystic Fibrosis Mutation Detection Test in UAE | 1800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by a Consultant Medical Geneticist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
Cystic Fibrosis Mutation Detection is a comprehensive genetic test that analyzes the CFTR gene for pathogenic variants using PCR and Next-Generation Sequencing (NGS). This test identifies causative mutations for cystic fibrosis, guiding early intervention for better pulmonary and nutritional outcomes. Early detection is critical per UAE genetic screening protocols.
| Feature | Our Test (Cystic Fibrosis Mutation Detection) | Standard PCR Panel (Limited) |
|---|---|---|
| Methodology | PCR + Next-Generation Sequencing (NGS) full CFTR gene analysis | Targeted PCR for few common mutations only |
| Sensitivity | Detects >99% of known pathogenic variants in UAE population | ~70% detection rate; misses rare mutations |
| Turnaround Time | 6 weeks (comprehensive interpretation) | 4-6 weeks (limited report) |
| Price | 1800 AED | 1200-1500 AED |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics (DHA: 9294403): "As a geneticist, I emphasize that this test must be interpreted within the full clinical context. A negative result does not completely exclude cystic fibrosis, and any pathogenic finding requires immediate referral to a paediatric pulmonologist and genetic counsellor for family planning and management."
Medication Advisory
⚠ Important: Do not discontinue any prescribed medication without consulting your doctor. Some treatments may affect test interpretation.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Patients on anticoagulants must inform the attending physician; amniotic fluid collection is performed only under obstetric guidance.
- Red Flags: Minor patients require legal guardian consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability. Seek immediate medical attention if there is bleeding, infection signs, or severe pain after sample collection.
- Emergency: For new or worsening respiratory distress, cyanosis, or meconium ileus in newborns, go to the nearest emergency department regardless of pending test results.
Patient FAQ & Clinical Guidance
1. How is the Cystic Fibrosis Mutation Detection test performed?
The test uses a blood sample or amniotic fluid obtained under strict sterile conditions. The specimen is analyzed by PCR combined with Next-Generation Sequencing (NGS) to detect pathogenic variants in the CFTR gene. Both sample types require collection in a hospital setting to ensure safety and accuracy.
2. Who should consider this test in the UAE?
This test is recommended for newborns with positive CF newborn screening, children with recurrent respiratory infections, and couples planning pregnancy with a family history of cystic fibrosis. Preconception carrier screening is also available for high-risk populations.
3. What genetic mutations does this test cover?
The assay sequences the entire CFTR gene, detecting over 2,000 known pathogenic variants including those common in the Arab population (e.g., F508del, W1282X). Results are interpreted by a Consultant Medical Geneticist and reported with clinical significance.
UAE Regulatory & Data Privacy Adherence
This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and safety are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. All laboratory processes are ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | Cystic Fibrosis Mutation Detection (CFTR Full Gene Analysis) |
| Price (AED) | 1800 AED |
| Turnaround Time | 6 weeks (comprehensive clinical report) |
| Sample Type / Matrix | Peripheral Whole Blood or Amniotic Fluid (Hospital Extraction Only) |
| Methodology Used | PCR + Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | E84.9 |
| LOINC Code | 47647-9 |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE) |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians